BridgeBio Pharma (BBIO) Q2 2025 Earnings

29AprConfirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-1.4
-1.06
-0.73
-0.39

Details

Expected EPS
-0.917948
Actual EPS
-0.88
Surprise EPS
0.04
Surprise Percent
+4.13%

Description

BridgeBio Pharma (BBIO) has reported earnings of -0.88 per share for Q2 2025.

0 Comments

Share your thoughts